
News
Biotech Firm Atai Life Sciences Plans to Buy $5 Million in Bitcoin
Atai Life Sciences, a NASDAQ-listed biopharmaceutical company, has announced plans to purchase $5 million worth of Bitcoin. The company, which develops mental health treatments using psychedelics such as DMT and MDMA, joins several other public medical companies that have recently invested in cryptocurrency. Christian Angermayer, founder and chair of Atai,